Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cytomegalovirus pp65 protein (UL83) is a major structural and tegument protein of Human cytomegalovirus (HCMV). It plays critical roles in immune evasion by inhibiting interferon responses, tegument assembly during virion morphogenesis, and transactivation of viral genes. pp65 is a major target for cellular and humoral immune responses and is widely used in diagnostic assays. While dispensable for replication in fibroblasts, it is essential for efficient growth in monocyte-derived macrophages. Targeting pp65 is an area of focus for developing immunotherapies and antiviral strategies against HCMV.
Not applicable as a drug target directly, but inhibition of its function or targeting it with antibodies are potential therapeutic strategies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytomegalovirus pp65 protein (pp65).